Hormonal factors and the risk of papillary thyroid cancer in the California teachers study cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1751-1759

  Horn Ross, Pamela L ^a   Canchola, Alison J ^a   Ma, Huiyan ^b   Reynolds, Peggy ^a   Bernstein, Leslie ^b  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED PUBERTY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REPRODUCTION; THYROID PAPILLARY CARCINOMA; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CALIFORNIA; CARCINOMA, PAPILLARY; COHORT STUDIES; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; MENARCHE; MIDDLE AGED; PARITY; PREGNANCY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; THYROID NEOPLASMS; YOUNG ADULT;

EID: 79961233613     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0381     Document Type: Article

References (31)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlander N, et al. SEER cancer statistics review, 1975-2006. Available from: http://seer.cancer. gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER website, 2009.
2. Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-95.
3. Horn-Ross P, Morris J, Lee M, West D, Whittemore A, McDougall I, et al. Iodine and thyroid cancer risk among women in a multiethnic population: The Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomark Prev 2001;10:979-86.
4. Preston-Martin S, Franceschi S, Ron E, Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control 2003;14:787-9. (Pubitemid 37463892)
5. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer II: Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-55. (Pubitemid 29161106)
6. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999;8:991-7. (Pubitemid 29536092)
7. Zivaljevic V, Vlajinac H, Jankovic R, Marinkovic J, Dzodic R, Sipeti Grujii S, et al. Case-control study of female thyroid cancer-menstrual, reproductive and hormonal factors. Eur J Cancer Prev 2003;12:63-6. (Pubitemid 36233024)
8. Brindel P, Doyon F, Rachedi F, Boissin J-L, Sebbag J, Shan L, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008;15:219-29.
9. Memon A, Darif M, Al-Saleh K, Suresh A. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 2002;97:82-9.
10. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-72. (Pubitemid 30461140)
11. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 2002;11:51-7. (Pubitemid 34118313)
12. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P. Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 2005;161:1056-65. (Pubitemid 40734354)
13. Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Reynolds P, et al. High breast cancer rates among California teachers: results from the California Teachers Study cohort. Cancer Causes Control 2002;13:625-35. (Pubitemid 35001770)
14. Kwong SL, Perkins CI, Morris CR, Cohen R, Allen M, Schlag R, et al. Cancer in California: 1988-1998. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section 2000.
15. Negri E, Ron E, Franceschi S, Dal Maso L, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control 1999;10:131-42. (Pubitemid 29161105)
16. Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983;57:82-6. (Pubitemid 13065449)
17. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS, et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010;171:242-52.
18. De Remigis P, Raggiunti B, Nepa A, Giandonato S, Faraone G, Sensi S. Thyroid volume variation during the menstrual cycle in healthy subjects. Prog Clin Biol Res 1990;341A:169-73.
19. Hegedus L, Karstrup S, Rasmussen N. Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 1986;155:142-5. (Pubitemid 16100547)
20. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York, New York: Oxford University Press; 2006. p. 975-94.
21. Zagrodzki P, Ratajczak R, Wietecha-Posluszny R. The interaction between selenium status, sex hormones, and thyroid metabolism in adolescent girls in the luteal phase of their menstrual cycle. Biol Trace Elem Res 2007;120:51-60. (Pubitemid 350085238)
22. Pike M, Spicer D, Danmoush L, Press M. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35. (Pubitemid 23269068)
23. Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis WW, et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidem Biomarkers Prev 2005;14:1514-20. (Pubitemid 40807355)
24. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999;10:157-66. (Pubitemid 29161107)
25. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001;93:745-50. (Pubitemid 32695128)
26. Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 2005;116:433-8. (Pubitemid 40993341)
27. Pham T-M, Fujino Y, Mikami H, Okamoto N, Hoshiyama Y, Tamakoshi A, et al. Reproductive and menstrual factors and thyroid cancer among Japanese women: the Japan Collaborative Cohort Study. 2009;18:331-5.
28. Lee ML, Chen GG, Vlantis AC, Tse GMK, Leung BCH, van Hasselt CA. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J 2005;11:113-21. (Pubitemid 44698822)
29. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions. Pol J Pathol 2002;53:67-72.
30. Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S, et al. Estrogen receptors (alpha and beta) and 17 beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Mod Pathol 2003;16:437-44. (Pubitemid 36618464)
31. Franceschi S, Dal Maso L. Hormonal imbalances and thyroid cancers in humans. Lyon, France: International Agency for Research on Cancer: IARC Scientific Publication No. 147; 1999.